Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma

Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F23%3A10000982" target="_blank" >RIV/00064190:_____/23:10000982 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00064190:_____/22:N0000044 RIV/00216208:11110/23:10447805
Výsledek na webu
<a href="https://doi.org/10.1111/all.15513" target="_blank" >https://doi.org/10.1111/all.15513</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/all.15513" target="_blank" >10.1111/all.15513</a>

Jazyk výsledku
angličtina
Název v původním jazyce
Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma
Popis výsledku v původním jazyce
To the Editor,Asthma is a heterogeneous disease, as reflected by differences in age of onset, severity, treatment response and inflammatory profile. Matrix metalloprotease (MMP)-12 has been associated with inflammation in various subtypes of asthma. In allergic asthma, MMP-12 activity has been implicated in the accumulation of neutrophils and eosinophils, in regulating macrophage functions and in the development of airway hyperresponsiveness (AHR).
Název v anglickém jazyce
Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma
Popis výsledku anglicky
To the Editor,Asthma is a heterogeneous disease, as reflected by differences in age of onset, severity, treatment response and inflammatory profile. Matrix metalloprotease (MMP)-12 has been associated with inflammation in various subtypes of asthma. In allergic asthma, MMP-12 activity has been implicated in the accumulation of neutrophils and eosinophils, in regulating macrophage functions and in the development of airway hyperresponsiveness (AHR).

Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Podobné výsledky(10)